Organ transplantation's most stubborn bottleneck — the chronic shortage of donor organs — may one day yield to a radically different supply chain: genetically engineered pigs. A milestone experiment now demonstrates that a pig liver and both kidneys can sustain basic physiological function in a human body for nearly five days without triggering the catastrophic immune rejection that has historically doomed xenotransplantation attempts.
The research team implanted a complete liver plus bilateral kidneys harvested from a six-gene-edited pig into a 53-year-old human decedent, then monitored graft performance continuously for close to five days. All three organs maintained measurable physiological activity throughout the observation window, and critically, no hyperacute rejection — the rapid, complement-driven graft destruction that historically ended early xenotransplant attempts within hours — was detected. Immune profiling using single-cell RNA sequencing identified an expansion of S100A12-positive neutrophils that appeared to serve as central communication nodes in early post-transplant intercellular signaling networks. Metabolomic analysis showed that systemic metabolic patterns post-transplant remained positively correlated with the recipient's pre-transplant baseline, albeit at generally elevated magnitudes, suggesting the xenografts were metabolically active and integrating into host physiology.
This experiment sits at a meaningful inflection point in xenotransplantation research. Earlier milestones — NYU Langone's 2021 pig kidney attached to a human decedent's vasculature, and the 2022 University of Maryland living-recipient pig heart transplant — demonstrated short-term tolerance but involved single organs or less complex vascular reconstructions. Simultaneously transplanting a whole liver alongside both kidneys is substantially more surgically and immunologically complex, as the liver's unique immunomodulatory properties may actually confer protective effects on co-transplanted organs, a hypothesis this dataset will help interrogate. The six-gene edits likely include human complement-regulatory transgenes and knockouts of porcine antigens known to trigger xenoreactivity, though the specific construct warrants scrutiny. Key limitations are substantial: decedent models cannot capture the full living immune milieu, systemic inflammation, or metabolic feedback loops present in critically ill transplant candidates. The neutrophil expansion signal is intriguing but mechanistically preliminary. This is incremental-to-significant progress — not a clinical breakthrough yet, but essential preclinical evidence that multi-organ pig-to-human transplantation is biologically feasible.